
Biotech · South San Francisco, United States
Atomic AI
Atomic AI uses AI and structural biology to redesign molecules, with an R&D platform built on Science-cover research to target RNA structure and tackle undruggable diseases, guided by an interdisciplinary computational and experimental biology team.
Work at Atomic AI?
- Location
- South San Francisco, United States
- Team size
- 11-50
- Founded 2021
- Total raised
- $42M
- Series A · last round Jan '23
About Atomic AI
Atomic AI is a well-funded, early-stage biotech company. It aims to transform the rational design of molecules and medicines through the fusion of artificial intelligence and structural biology. Its R&D platform is based on research featured on the cover of Science (doi.org/10.1126/science.abe5650). The platform provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. Atomic AI describes itself as an interdisciplinary team working across computational and experimental biology.
Culture & values
We are an interdisciplinary team working across computational and experimental biology.
We believe that our strongest asset is our people.
The team at Atomic AI
11-50 peopleSee everyone on LinkedIn
Location
Frequently asked questions
Atomic AI is based in South San Francisco, United States.
Ask your AI about Atomic AI
Connect Clera once, then ask what they're hiring for.
Ask about this company
Tell me about Atomic AI (https://www.getclera.com/companies/atomic-ai). Then find open roles at similar startups on Clera that fit my profile.
Not connected yet? Takes a minute
https://mcp.getclera.comSign in with your Clera account. MCP docs
Companies similar to Atomic AI
Arceus is building the legal infrastructure layer for modern companies by combining experienced attorneys with intelligent technology to deliver high-quality legal services at the speed growing businesses demand. The company addresses a critical gap between legal teams' need to move faster across commercial, product, privacy, procurement, and operational work and the outdated tools and delivery models currently available. By transforming legal judgment and playbooks into scalable, innovative products, Arceus aims to reinvent how companies receive legal support. Operating in a trillion-dollar market with significant demand for its solutions, the company is positioned to fundamentally change the way modern businesses access and manage legal expertise.
We're building the first AI-native go-to-market agency in the DACH region. Since 2024, we've grown to over €5M ARR and a team of 30+, working with more than 200 leading B2B tech companies.
Augustus is building the global dollar bank. Moving dollars across borders still runs on correspondent banking, a chain of intermediaries that is slow, opaque, and expensive. Augustus replaces it with programmable USD and EUR accounts, direct clearing and settlement, and an AI-native core banking platform built from scratch. The moat is the license. Augustus holds OCC conditional approval for a US national bank charter, which is rare and very hard to replicate, and euro clearing is live today for customers including Kraken. $180M Series B at a $1B valuation, led by Tiger Global with QED, plus operators from Nubank, Ramp, Circle, Revolut, and Coinbase. Fewer than 50 people, in NYC and Berlin.